We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PCAR:NASDAQPACCAR Inc. Analysis

Data as of 2026-05-21 - not real-time

$107.90

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

PACCAR Inc (PCAR) is trading at $107.9, just above its computed support of $107.87, indicating limited downside in the immediate term. The stock sits below its 20‑day ($115.0) and 50‑day ($117.8) moving averages, and the MACD line remains beneath the signal, signaling a short‑term bearish bias. However, the RSI of 34 points to a near‑oversold condition, suggesting potential for a technical rebound. Fundamentals show an 8.9% revenue contraction year‑over‑year to $6.78 billion, yet operating margins stay healthy at 10.3% and free cash flow exceeds $1.4 billion. The forward earnings estimate of $6.77 per share translates to a forward P/E of roughly 16×, well below the industry average of 29×, highlighting relative value. With a dividend yield of 1.25% and a payout ratio under 30%, the dividend appears sustainable given the robust cash flow generation. The company’s leverage is moderate (debt‑to‑equity ~76%) and net debt is offset by $8.6 billion of cash, limiting financial risk.
Analyst consensus remains a “Buy” with a median price target of $125, implying roughly a 16% upside from current levels. The market’s “Extreme Greed” sentiment (Fear‑Greed Index 90.7) may be inflating short‑term optimism, but the stock’s beta of ~1.0 suggests price moves are in line with broader market volatility. Volatility over the past 30 days is high at 28.8%, and volume trends are decreasing, which could exacerbate price swings. Geographic diversification across North America, Europe, and Latin America reduces regional concentration risk. Ongoing regulatory pressure on diesel engines presents a medium‑level risk, yet PACCAR’s investment in alternative powertrains may mitigate this over time. Considering the blend of value metrics, modest growth outlook, and a sustainable dividend, the investment case leans toward a longer‑term hold. In summary, the stock is presently at a technical inflection point with limited downside, modest upside potential, and a solid fundamentals foundation.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • price near support
  • bearish MACD
  • decreasing volume

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • forward PE advantage
  • analyst upside potential
  • sustainable dividend

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • industry tailwinds
  • diversified geography
  • strong cash flow

Key Metrics & Analysis

Financial Health

Revenue Growth-8.90%
Profit Margin8.91%
P/E Ratio23.0
ROE13.11%
ROA4.15%
Debt/Equity76.16
P/B Ratio2.9
Op. Cash Flow$4.5B
Free Cash Flow$1.5B
Industry P/E29.3

Technical Analysis

TrendNeutral
RSI34.0
Support$107.87
Resistance$128.58
MA 20$115.04
MA 50$117.80
MA 200$110.43
MACDBearish
VolumeDecreasing
Fear & Greed Index90.71

Valuation

Fair Value$23.96
Target Price$126.12
Upside/Downside16.89%
GradeUndervalued
TypeBlend
Dividend Yield1.25%

Risk Assessment

Beta0.98
Volatility28.80%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.